Position in AMGN
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$23,701,113
+$724,608 QoQ
Shares Held
65,451
+0.2% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
1.27%
of 13F equity value
Holder Rank
#345
of 3,140 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MEEDER ASSET MANAGEMENT INC holds $140,500,918 across 9 Drug Manufacturers - General names. AMGN ranks #4 (16.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
28,922 | $34,689,912 | |
| 2 | JNJ |
Johnson & Johnson
|
117,192 | $29,763,248 | |
| 3 | ABBV |
AbbVie Inc.
|
98,512 | $24,789,557 | |
| 4 | AMGN |
Amgen Inc
This page
|
65,451 | $23,701,113 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
135,547 | $17,125,003 | |
| 6 | MRK |
Merck & Co., Inc.
|
71,755 | $9,220,516 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
20,426 | $1,176,942 | |
| 8 | PFE |
Pfizer Inc
|
1,115 | $26,849 |
All Filings in AMGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23,701,113 | 65,451 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $22,976,505 | 65,302 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $21,666,936 | 66,197 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $19,333,520 | 68,510 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $11,426,945 | 40,926 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $11,264,086 | 36,155 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $36,489 | 140 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $17,219,865 | 53,443 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $14,562,669 | 46,608 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $1,246,174 | 4,383 | Shares | Defined | 2024-05-07 | |
| 2023-12-31 | $18,609,259 | 64,611 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $543,432 | 2,022 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $10,832,355 | 48,790 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $6,748,205 | 27,914 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $6,095,608 | 23,209 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $14,686,157 | 65,156 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $14,381,459 | 59,110 | Shares | Defined | 2022-08-08 | |
| 2022-03-31 | $13,423,908 | 55,512 | Shares | Defined | 2022-05-10 | |
| 2021-09-30 | $9,024,649 | 42,439 | Shares | Defined | 2021-11-08 | |
| 2021-06-30 | $10,468,818 | 42,949 | Shares | Defined | 2021-08-09 | |
| 2021-03-31 | $10,582,382 | 42,532 | Shares | Defined | 2021-04-28 | |
| 2020-12-31 | $1,632,432 | 7,100 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $11,069,935 | 43,555 | Shares | Defined | 2020-11-02 | |
| 2020-06-30 | $12,007,157 | 50,908 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $10,519,453 | 51,889 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||